Indogulf Cropsciences LimitedChemicalsIGCL
Q1 FY27 concall · earnings callIndogulf Cropsciences Limited
Indogulf's Q1 FY27 revenue declined 11% YoY due to delayed and uneven monsoons impacting sowing and demand, but gross margins expanded significantly to 28% from better product mix and procurement discipline.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue from Operations | ₹168.5 Cr | -11% | |
| Gross Margin | 28% | — | |
| EBITDA Margin | 5.7% | — | |
| PAT | ₹2.4 Cr | — | |
| PAT Margin | 1.4% | — | |
| Capacity Utilization | 70% | — | |
| Capital Work-in-Progress | ₹76.4 Cr | — | |
| Captive Consumption of Technicals | 34% | — |
PAT fell 40% quarter-over-quarter — ₹2.4 Cr, from Rs.三种.4 crores in Q1 FY26.
The prior summary is for Q1 FY27, which is the same quarter reported in this transcript. Therefore, there is no comparison against a prior-quarter summary; this is the primary report.
- Revenue fell 11% YoY to Rs. 168.5 crores due to delayed monsoons, cautious channel inventory, and pricing pressure.
- Gross margin improved to 28% from 22% due to better cost and product mix, with gross profit up 12%.
- EBITDA margin improved to 5.7% from 5.2% despite a softer top line, reflecting operational resilience.
- Capacity utilization increased to 70% from 52% in FY26.
- Captive consumption of technicals increased to 34% from 22% in Q1 FY26.
- Management is focusing on specialty products, biologicals, international expansion, and deepening farmer engagement.
“We view a meaningful part of this weakness as time-related, which is characteristic with the seasonality of our sector, rather than a structural change in the business.”
| Topic | What management said |
|---|---|
| Revenue Growth Forecast | Management declined to give specific growth targets for FY27, citing a challenging Q1 and industry-wide issues, but stated they are working aggressively for good growth. |
| Capacity and Peak Revenue | Management stated peak turnover with current capacity is Rs. 1100-1200 crores, and with expanded capacity, they can reach Rs. 1800 crores in approximately 4-5 years. |
| Backward Integration Benefit | Captive consumption of technicals improved to 34% in Q1 FY27, providing cost competitiveness and supply management strength. |
| Channel Inventory and Monsoon Impact | Management noted the entire value chain is making conservative decisions due to El Nino, with channel inventory low and price pressure present, but turnover has improved in the current peak period. |
| Biological and Nutrition Segment Growth | Management highlighted aggressive plans for the biological and nutrient segment, including product development and collaboration with ICAR-IARI. Sales for this segment grew to 22% of brand sales in Q1 FY27 compared to 11% in the prior year. |
| Finance Cost Increase | Finance cost rose 19% YoY due to material purchases anticipating good sales, but management expects to reduce it as inventory liquidates and collections improve. |
| Raw Material Cost Outlook | Management stated raw material prices corrected and stabilized in Q2, though still incrementally higher than last year, especially for packaging (up ~40%) and logistics. |
- Focus on expanding biological and sustainable product portfolio.
- Increase contribution from specialty and higher-value products.
- Deepen farmer engagement through advisory-led model.
- Accelerate international expansion.
- Focus on procurement, supply chain, and manufacturing efficiencies.
- Improve utilization of existing infrastructure.
Summary written from the transcript filed by Indogulf Cropsciences Limited for the call held on 18 Aug 2026; published 21 Aug 2026, 15:05 IST.
More Q1 FY27 concalls ·How verification works ·Report an error